NCT00085852View on ClinicalTrials.gov

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

June 30, 2007

Conditions
Pulmonary Emphysema
Interventions
BIOLOGICAL

BLVR

10 mL Hydrogel

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

02135

Caritas St Elizabeth's Medical Center, Boston

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00085852 - US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation | Biotech Hunter | Biotech Hunter